Enisoprost

依尼前列素

Report date: 2023/04/25 14:52:25

NME

Base Information

Drug NameEnisoprost

Drug Alias NameSC-34301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstanoid receptor agonistsImmunosuppressants

TargetsProstanoid receptor

Therapy Area/IndicationsRejection of organ transplantationPeptic Ulcer

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationPeptic Ulcer

ATC CodeN/A